Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Idera Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Idera Pharmaceuticals

Rahul Jasuja, Ph.D. has been named vice president of corporate development at Idera Pharma.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rahul Jasuja, Ph.D. has been named vice president of corporate development at Idera Pharmaceuticals. Dr. Jasuja previously served as managing director, Life Sciences at MDB Capital Group, a life sciences and technology merchant and investment bank.

“Rahul brings extensive and relevant scientific understanding and experience in the capital markets to Idera,” commented Sudhir Agrawal, D.Phil., chief executive officer and chief scientific officer. “We welcome Rahul to our team and expect him to play a key role in the Company as we continue to advance our drug discovery and development programs with agonists, antagonists, and antisense targeted to toll-ike receptors (TLRs).”

Dr. Jasuja joined MDB Capital Group in 2004, leading its life sciences research effort as Senior Biotechnology Research Analyst. He conducted due-diligence on private companies and initiated research reports on several public biotechnology companies, including Idera. He previously worked in similar roles at Rodman & Renshaw and Techvest LLC.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics